Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
20 studies found for:    "Stevens-Johnson syndrome"
Show Display Options
Rank Status Study
1 Completed Stevens-Johnson Syndrome Antimicrobial
Condition: Stevens-Johnson Syndrome
Intervention:
2 Completed Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye
Condition: Stevens-Johnson Syndrome
Intervention: Drug: 0.05%cyclosporin eye drop
3 Unknown  Corneal Epitheliotropic Factors in Autologous Serum Eye Drops in Nonautoimmune and Stevens-Johnson Syndrome With Dry Eye
Condition: Stevens-Johnson Syndrome
Intervention:
4 Completed Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.
Conditions: Stevens-Johnson Syndrome;   Toxic Epidermal Necrolysis
Intervention: Drug: Intravenous immunoglobulin
5 Not yet recruiting Cyclosporine and Etanercept in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Conditions: Stevens-Johnson Syndrome;   Toxic Epidermal Necrolyses
Interventions: Drug: cyclosporin A;   Drug: Etanercept 50 MG Solution for Injection;   Drug: Placebos
6 Withdrawn Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Conditions: Stevens-Johnson Syndrome;   Corneal Blindness
Intervention: Drug: Infliximab
7 Terminated
Has Results
Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis
Conditions: Toxic Epidermal Necrolysis;   Stevens-Johnson Syndrome
Intervention: Drug: Palifermin
8 Completed Salivary Gland Transplantation in the Treatment of Dry Eye in Patients With Stevens-Johnson Syndrome.
Conditions: Symblepharon;   Dry Eye;   Ocular Surface Disease;   Transplantation
Intervention: Procedure: Salivary Gland and Labial Mucous Membrane Transplantation
9 Enrolling by invitation Topical Infliximab in Autoimmune Eyes With Keratoprosthesis
Conditions: Stevens-Johnson Syndrome;   Toxic Epidermal Necrolysis (Lyell) Syndrome;   Mucous Membrane Pemphigoid
Intervention: Drug: topical infliximab
10 Completed Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation
Conditions: Pterygium;   Ocular Surface Disease;   Stevens Johnson Syndrome;   Chemical Injury
Intervention: Procedure: Cultivated conjunctival transplantation
11 Available Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation
Conditions: Limbal Stem Cell Deficiency;   Stevens-johnson Syndrome;   Ocular Cicatricial Pemphigoid;   Chemical Burn
Intervention: Biological: cultivated oral mucosal epithelial sheet transplantation
12 Recruiting G-CSF in the Treatment of Toxic Epidermal Necrolysis
Condition: Stevens - Johnson Syndrome
Interventions: Drug: recombinant granulocyte - colony stimulating factor;   Drug: NaCl 0.9%
13 Not yet recruiting Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
Condition: Toxic Epidermal Necrolysis
Intervention: Drug: Clobetasol 0.05% ointment
14 Withdrawn Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)
Condition: Toxic Epidermal Necrolysis
Intervention: Drug: Remicaide (infliximab)
15 Active, not recruiting Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation
Conditions: Graft vs Host Disease;   Congenital Aniridia;   Chemical Burns;   Stevens-Johnson Syndrome;   Congenital Glaucoma
Intervention: Device: ARGOS-IO system
16 Recruiting Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study
Condition: Toxic Epidermal Necrolysis
Interventions: Drug: Isotretinoin;   Other: Placebo
17 Recruiting Severe Cutaneous Adverse Reactions in Thailand
Conditions: Steven-Johnson Syndrome;   Toxic Epidermal Necrolysis;   Drug Reaction With Eosinophilia and Systemic Symptoms;   Acute Generalized Exanthematous Pustulosis;   Generalized Bullous Fixed Drug Eruption
Intervention:
18 Recruiting Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
Conditions: Chemical Injuries;   Unspecified Complication of Corneal Transplant;   Autoimmune Diseases;   Ocular Cicatricial Pemphigoid;   Stevens Johnson Syndrome;   Lupus Erythematosus, Systemic;   Rheumatoid Arthritis;   Other Autoimmune Diseases
Intervention: Drug: Riboflavin
19 Unknown  Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell Deficiency
Condition: Limbal Stem Cell Deficiency
Intervention: Procedure: Cultivated limbal stem cell graft transplantation
20 Terminated Lamictal in the Treatment of Post-Herpetic Neuralgia
Condition: Neuralgia, Postherpetic
Intervention: Drug: Lamictal in the treatment of Post-Herpetic Neuralgia

Study has passed its completion date and status has not been verified in more than two years.